Endovia Health Sciences (EDVA) Property, Plant & Equipment (Net) Growth (5y) (2018 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Property, Plant & Equipment (Net) Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.06 Bn | 133.21 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.96 Bn | 78.97 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.74 Bn | 1.37 Bn |
| 4 | Moderna | 57.22 Bn | 52.08 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.59 Bn | 44.59 Bn | - |
| 6 | BeOne Medicines | 40.43 Bn | 35.33 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.17 Bn | 27.34 Bn | - |
| 9 | Insmed | 27.60 Bn | 26.43 Bn | 358.27 Mn |
| 10 | Endovia Health Sciences | 821,701.01 | 578,999.01 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -55.98% |
| Dec 31, 2025 | -54.75% |
| Sep 30, 2025 | 9.64% |
| Jun 30, 2025 | 15.27% |
| Mar 31, 2025 | 17.75% |
| Dec 31, 2024 | -10.06% |
| Sep 30, 2024 | 41.69% |
| Jun 30, 2024 | 43.92% |
| Mar 31, 2024 | 44.80% |
| Dec 31, 2023 | 42.94% |
| Sep 30, 2023 | 54.59% |
| Jun 30, 2023 | 59.65% |
| Mar 31, 2023 | 58.15% |
| Dec 31, 2022 | 60.04% |
| Sep 30, 2022 | 58.23% |
| Jun 30, 2022 | 52.86% |
| Mar 31, 2022 | 53.56% |
| Dec 31, 2021 | 55.74% |
| Sep 30, 2021 | 55.35% |
| Jun 30, 2021 | 66.18% |